Case report
A 65-year-old Dutch Caucasian woman presented at the department of pulmonary diseases in a peripheral hospital with fever, fatigue and dyspnea. There were dense airspace opacities in both lungs visible on chest radiographs after a 2-month-period of recurrent pneumonias of various lobes. The patient had a 30-year history of rheumatoid factor positive rheumatoid arthritis for which she had received for 3 years the tumor necrosis factor a neutralizing agent infliximab. Infliximab suppresses the immune system and predisposes to opportunistic infections, including mycobacterial disease [1] . The patient reported no additional risk factors for mycobacterial disease, but she had visited Zimbabwe during the previous year.
In the first month after initial presentation she received the broad-spectrum antibiotics amoxicillin/clavulanic acid and doxycycline because of the recurrent pneumonias. Thereafter infliximab was replaced by methotrexate. This led initially to clinical improvement, however, later the patient experienced relapses of fever up to 38.0°C, dry cough, malaise and fatigue. After 2 months, a chest radiograph showed infiltrative abnormalities of the right middle lobe. A computed tomography (CT)-scan and a high-resolution-CTscan (HCRT) revealed some atypical fibrosis, especially in the lower zones of the lungs; also visible on the CT-scan was a small, localized dense nodule in the anterobasal segment of the right lower lobe (Figs. 1A and 1B). A sputum culture grew Mycobacterium avium, as identified by Inno-LiPA Mycobacteria v2 assay (Innogenetics, Ghent, Belgium).
Four months after initial presentation, the patient was admitted to the rheumatology outpatient clinic because of right middle lobe (RML) pneumonia. She presented with an acute, continued pain in the right hemithorax, a stinging pain under her right breast, and fever up to 39.8°C. Her symptoms also included cough without sputum, weight loss and night sweats. Auscultation of the chest revealed bilateral basal coarse crepitations and no rhonchi. A chest radiograph revealed dense airspace opacities in the RML. Culture of a bronchoalveolar lavage (BAL) also grew M. avium. Empirical therapy was started with thrice daily amoxicillin/clavulanic acid 1200 mg intravenous and ciproxin 400 mg intravenous twice daily. Thereafter, the patient improved clinically. Follow-up chest radiographs showed improvement, but incomplete resolution of the lesions.
Six months after initial presentation, the symptoms -fever and fatigue -continued. A renewed interview revealed that 4 months before initial presentation, the patient had an indoor hot tub installed. A water sample of the hot tub was collected for culture. Ziehl-Neelsen stain of a sediment was reported [2] and corresponding cultures grew M. avium. The patient was advised to discontinue hot tub use and this led after 4 and 9 months to negative cultures of M. avium.
Genotyping was performed on all three M. avium isolates using IS1245 restriction fragment length polymorphism (RFLP) typing, as previously described [3] . IS1245 RFLP revealed that all three isolates belong to a single M. avium subsp. hominissuis strain ( Fig. 2A) . The secondary genotyping method applied to the three isolates was rep-PCR, a commercially available system (DiversiLab â , bioMé rieux). For M. avium subsp. hominissuis, the discriminative power of rep-PCR was previously found to equal or exceed that of RFLP typing [4] . Rep-PCR confirmed that all three isolates belong to a single strain (Fig. 2B) .
Kahana et al. [5] also described a case of M. avium infection in an immunocompetent patient in relation to M. avium cultured from a hot tub. Both strains revealed a high degree of similarity in multilocus enzyme electrophoresis and IS1245 RFLP analysis, although the IS1245 RFLP of the hot tub isolate revealed three additional bands compared with the isolate from an open-lung biopsy specimen.
In the current study, on the basis of two typing methods, indistinguishable M. avium subsp. hominissuis isolates from the patient and the hot tub were found, and this contrasts the study of Kahana et al. The patient also directly improved after discontinuing the hot tub use. Antibacterial therapy was provided, but not focused on treatment of an M. avium infection. The diagnosis of hypersensitivity pneumonitis was hominissuis isolates from (1) sputum cultured 2 months after initial presentation; (2) BAL cultured 5 months after initial presentation; and (3) hot tub water cultured 7 months after initial presentation.
initially based on the clinical and radiological presentation, but because typing of the M. avium cultures from the patient and the hot tub yielded identical profiles and the patient directly improved when she discontinued the use of the hot tub, it is conceivable these bacteria were indeed the cause of her infection.
The ATS/IDSA guidelines for nontuberculous mycobacterial disease [6] state that ''[without histological evidence], a diagnosis of M. avium-associated hypersensitivity-like lung disease can be established by the following: subacute onset of respiratory symptoms; hot-tub exposure; characteristic radiographic findings; and M. avium isolates in sputum, BAL, tissue, and hot-tub water.'' Our patient matches this case definition.
The treatment of a case of hypersensitivity pneumonitis is the subject of debate. The disease results either from inflammation, infection, or both; as a result, treatment can consist of steroids or antimycobacterial treatment. For the latter, the ATS/IDSA statement [6] recommends rifampicin, ethambutol and a macrolide antibiotic, for M. avium. Neither antimycobacterial treatment, nor steroids were given.
In summary, a case of M. avium subsp. hominissuis hypersensitivity pneumonitis is described in a patient with rheumatoid arthritis treated with infliximab, related to hot tub exposure. Genotyping revealed that the isolates from sputum, lung lavage and hot tub water belonged to a single strain of M. avium subsp. hominissuis. Discontinuation of the use of the hot tub led to significant improvement.
